MENTHOL, UNSPECIFIED FORM

MENTHOL, UNSPECIFIED FORM was reported 632 times

MENTHOL, UNSPECIFIED FORM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE CYST 1 0.0312
1 VICTIM OF SPOUSAL ABUSE 2 0.0312
2 THIRD DEGREE CHEMICAL BURN OF SKIN 1 0.0238
3 TESTICULAR INJURY 1 0.0238
4 ROTAVIRUS TEST POSITIVE 1 0.0222
5 ENZYME LEVEL ABNORMAL 2 0.0143
6 MUSCLE TENSION DYSPHONIA 1 0.0125
7 INFUSION SITE STREAKING 1 0.0115
8 INFUSION SITE PARAESTHESIA 1 0.0099
9 CHEMICAL BURN 11 0.0095
10 PARANOID PERSONALITY DISORDER 1 0.0076
11 LARGE INTESTINAL POLYPECTOMY 1 0.0061
12 URINARY RETENTION POSTOPERATIVE 1 0.0061
13 RENAL VASCULAR THROMBOSIS 1 0.0058
14 INFUSION SITE INJURY 1 0.0057
15 DEVICE MAINTENANCE ISSUE 3 0.0051
16 LIPOEDEMA 2 0.0051
17 BURNS THIRD DEGREE 5 0.0047
18 PATIENT ISOLATION 1 0.0047
19 BENDOPNOEA 1 0.0045
20 STROKE IN EVOLUTION 1 0.0045
21 ORAL CONTUSION 1 0.0043
22 APPLICATION SITE BURN 21 0.0043
23 GESTATIONAL HYPERTENSION 5 0.0039
24 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
25 CATHETERISATION CARDIAC ABNORMAL 1 0.0037
26 CHEMICAL BURNS OF EYE 1 0.0036
27 BURNS SECOND DEGREE 6 0.0034
28 CAUSTIC INJURY 1 0.0032
29 CARBON DIOXIDE ABNORMAL 1 0.0032
30 SALIVA DISCOLOURATION 1 0.0030
31 GASTROINTESTINAL POLYP 1 0.0030
32 MULTIPLE SCLEROSIS PSEUDO RELAPSE 1 0.0029
33 DIVERTICULITIS INTESTINAL PERFORATED 1 0.0028
34 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
35 SENSATION OF BLOOD FLOW 1 0.0026
36 VASCULAR INSUFFICIENCY 1 0.0026
37 MITRAL VALVE REPLACEMENT 1 0.0025
38 CHEMICAL INJURY 2 0.0024
39 BELLIGERENCE 1 0.0023
40 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 1 0.0022
41 MEIBOMIAN GLAND DYSFUNCTION 1 0.0022
42 PLICATED TONGUE 1 0.0021
43 VITREOUS DISORDER 1 0.0021
44 EXERCISE LACK OF 1 0.0021
45 ARTIFICIAL CROWN PROCEDURE 1 0.0020
46 SKIN OEDEMA 2 0.0020
47 INFUSION SITE ABSCESS 1 0.0020
48 TRANSPLANT EVALUATION 1 0.0020
49 LIGAMENT PAIN 1 0.0019
50 NASAL ULCER 3 0.0019
51 MEDICAL DEVICE CHANGE 1 0.0019
52 ENZYME ABNORMALITY 1 0.0019
53 STOMA SITE IRRITATION 1 0.0018
54 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
55 NAIL INJURY 1 0.0018
56 INFUSION SITE DISCHARGE 3 0.0017
57 DEEP BRAIN STIMULATION 1 0.0017
58 SACRAL PAIN 1 0.0016
59 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
60 APPLICATION SITE SCAR 2 0.0016
61 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
62 STAPHYLOCOCCAL ABSCESS 1 0.0016
63 SCLERAL DISCOLOURATION 1 0.0015
64 POST PROCEDURAL SEPSIS 1 0.0015
65 INFLAMMATORY PAIN 1 0.0015
66 RHONCHI 2 0.0014
67 INFUSION SITE INFLAMMATION 1 0.0014
68 DERMATITIS DIAPER 1 0.0014
69 GLASSY EYES 1 0.0014
70 CERVICAL RADICULOPATHY 1 0.0014
71 PARASOMNIA 1 0.0014
72 IMMUNISATION REACTION 1 0.0014
73 INFUSION SITE INDURATION 2 0.0013
74 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
75 ALLERGIC COUGH 1 0.0013
76 STOMA SITE HAEMORRHAGE 2 0.0013
77 BLISTER INFECTED 1 0.0013
78 POST-TRAUMATIC NECK SYNDROME 1 0.0012
79 SHOULDER FRACTURE 2 0.0012
80 INFUSION SITE HAEMORRHAGE 4 0.0012
81 GIANT CELL ARTERITIS 1 0.0012
82 GASTROENTERITIS SALMONELLA 1 0.0012
83 INFUSION SITE OEDEMA 1 0.0012
84 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
85 INFECTED BITE 1 0.0012
86 MALIGNANT HYPERTENSION 1 0.0012
87 CYSTOCELE 1 0.0012
88 SPINAL CORD NEOPLASM 1 0.0011
89 THERMAL BURN 8 0.0011
90 OROPHARYNGEAL CANDIDIASIS 1 0.0011
91 CERUMEN IMPACTION 1 0.0011
92 BONE CONTUSION 1 0.0011
93 APPLICATION SITE VESICLES 7 0.0011
94 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
95 NECK MASS 3 0.0011
96 GESTATIONAL DIABETES 5 0.0010
97 BONE SWELLING 1 0.0010
98 NECK INJURY 3 0.0010
99 DIPLEGIA 2 0.0010
100 ONYCHALGIA 1 0.0010
101 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
102 CARDIAC DISCOMFORT 2 0.0010
103 SPONTANEOUS HAEMORRHAGE 1 0.0010
104 BREAST DISCOMFORT 1 0.0010
105 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 1 0.0010
106 RESPIRATORY TRACT IRRITATION 1 0.0010
107 SINUSITIS BACTERIAL 1 0.0009
108 NASAL INFLAMMATION 1 0.0009
109 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
110 TRAUMATIC HAEMATOMA 1 0.0009
111 INFUSION SITE BRUISING 2 0.0009
112 INFUSION SITE MASS 1 0.0009
113 SOFT TISSUE DISORDER 1 0.0009
114 SPINAL COLUMN INJURY 2 0.0009
115 OPEN WOUND 1 0.0009
116 GASTROINTESTINAL BACTERIAL INFECTION 1 0.0009
117 NECK SURGERY 2 0.0009
118 TONGUE HAEMORRHAGE 1 0.0009
119 SKIN ABRASION 4 0.0008
120 RECTAL PROLAPSE 1 0.0008
121 HAEMATOLOGICAL INFECTION 2 0.0008
122 INFUSION SITE WARMTH 1 0.0008
123 DEVICE INFUSION ISSUE 2 0.0008
124 HYPERPARATHYROIDISM SECONDARY 2 0.0008
125 BRONCHIAL SECRETION RETENTION 1 0.0008
126 APPLICATION SITE WARMTH 1 0.0008
127 BLOOD BILIRUBIN ABNORMAL 1 0.0008
128 ADENOCARCINOMA PANCREAS 1 0.0008
129 APPLICATION SITE EROSION 1 0.0008
130 STOMA SITE INFECTION 1 0.0008
131 WEIGHT BEARING DIFFICULTY 2 0.0007
132 BODY MASS INDEX INCREASED 1 0.0007
133 APPLICATION SITE DISCOLOURATION 3 0.0007
134 CARBON DIOXIDE INCREASED 1 0.0007
135 SKIN DEPIGMENTATION 1 0.0007
136 INFUSION SITE RASH 1 0.0007
137 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 1 0.0007
138 CARDIOVERSION 1 0.0007
139 INFUSION SITE ERYTHEMA 6 0.0007
140 CONNECTIVE TISSUE DISORDER 1 0.0007
141 GLUTEN SENSITIVITY 1 0.0007
142 JOINT LOCK 2 0.0007
143 BLOOD ELECTROLYTES DECREASED 1 0.0007
144 PULMONARY SEPSIS 1 0.0007
145 STOMA SITE PAIN 1 0.0007
146 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
147 GINGIVAL SWELLING 3 0.0007
148 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
149 PORTAL HYPERTENSION 2 0.0006
150 ORAL MUCOSAL ERYTHEMA 1 0.0006
151 SUBSTANCE USE 1 0.0006
152 PRE-EXISTING CONDITION IMPROVED 4 0.0006
153 MEDICAL DEVICE IMPLANTATION 1 0.0006
154 MEGACOLON 1 0.0006
155 SEASONAL ALLERGY 9 0.0006
156 INFUSION SITE SWELLING 4 0.0006
157 PHARYNGEAL PARAESTHESIA 1 0.0006
158 CYSTITIS INTERSTITIAL 1 0.0006
159 SKIN EROSION 2 0.0006
160 HYPERVOLAEMIA 3 0.0006
161 INJECTION RELATED REACTION 1 0.0006
162 DRUG SCREEN NEGATIVE 1 0.0006
163 FOOD INTERACTION 1 0.0006
164 INDURATION 1 0.0006
165 APPLICATION SITE DISCOMFORT 1 0.0006
166 METASTATIC RENAL CELL CARCINOMA 1 0.0005
167 ESSENTIAL HYPERTENSION 1 0.0005
168 BLOOD THYROID STIMULATING HORMONE ABNORMAL 1 0.0005
169 PLASMACYTOMA 1 0.0005
170 STOMA SITE ERYTHEMA 1 0.0005
171 PANCREATIC CYST 1 0.0005
172 MOTION SICKNESS 1 0.0005
173 MUSCLE RUPTURE 2 0.0005
174 NASAL SEPTUM DEVIATION 1 0.0005
175 CHANGE OF BOWEL HABIT 1 0.0005
176 TONGUE BITING 1 0.0005
177 AKINESIA 1 0.0005
178 LIVE BIRTH 4 0.0005
179 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
180 CATHETER SITE ERYTHEMA 1 0.0005
181 BLOOD TESTOSTERONE INCREASED 1 0.0005
182 MUSCLE STRAIN 4 0.0005
183 APPLICATION SITE ERYTHEMA 12 0.0005
184 BIPOLAR I DISORDER 1 0.0005
185 COLONOSCOPY 1 0.0005
186 PARESIS 1 0.0004
187 HAEMATOCRIT INCREASED 1 0.0004
188 INFUSION SITE INFECTION 1 0.0004
189 ROSACEA 2 0.0004
190 SINUS PAIN 1 0.0004
191 VOLVULUS 1 0.0004
192 LIMB OPERATION 2 0.0004
193 PAINFUL RESPIRATION 1 0.0004
194 BURSITIS 5 0.0004
195 CARTILAGE INJURY 1 0.0004
196 EXPIRED DRUG ADMINISTERED 2 0.0004
197 APPLICATION SITE SWELLING 2 0.0004
198 INFUSION SITE PAIN 5 0.0004
199 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
200 CATHETER SITE PAIN 1 0.0004
201 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
202 MULTIPLE ALLERGIES 3 0.0004
203 INJECTION SITE DISCHARGE 2 0.0004
204 PRODUCT RESIDUE PRESENT 2 0.0004
205 CHONDROPATHY 1 0.0004
206 ANORGASMIA 1 0.0004
207 DECUBITUS ULCER 3 0.0004
208 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
209 STOMA SITE DISCHARGE 1 0.0004
210 APPLICATION SITE PAIN 8 0.0004
211 HYPERKERATOSIS 2 0.0004
212 DRUG SCREEN FALSE POSITIVE 1 0.0004
213 NERVE INJURY 4 0.0004
214 ELECTRIC SHOCK SENSATION 1 0.0004
215 DRUG TOLERANCE DECREASED 1 0.0004
216 RESPIRATORY SYMPTOM 1 0.0004
217 DERMATITIS CONTACT 4 0.0004
218 HYPERTONIC BLADDER 1 0.0003
219 LUMBAR SPINAL STENOSIS 1 0.0003
220 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
221 ATYPICAL PNEUMONIA 1 0.0003
222 DYSCHEZIA 1 0.0003
223 MUSCULOSKELETAL CHEST PAIN 5 0.0003
224 APPLICATION SITE IRRITATION 4 0.0003
225 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
226 TESTICULAR PAIN 1 0.0003
227 ORTHOPNOEA 1 0.0003
228 PLASMA CELL MYELOMA RECURRENT 1 0.0003
229 INJECTION SITE INFECTION 1 0.0003
230 INABILITY TO AFFORD MEDICATION 3 0.0003
231 BREAST MASS 2 0.0003
232 LIMB INJURY 8 0.0003
233 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
234 GINGIVAL BLEEDING 4 0.0003
235 SCAR 5 0.0003
236 RIB FRACTURE 6 0.0003
237 CORONARY ARTERY OCCLUSION 4 0.0003
238 HEPATIC FIBROSIS 1 0.0003
239 LYMPHOEDEMA 2 0.0003
240 DEPRESSION SUICIDAL 1 0.0003
241 MASS 4 0.0003
242 BLISTER 16 0.0003
243 HANGOVER 1 0.0003
244 JOINT DISLOCATION 3 0.0003
245 SKIN WEEPING 1 0.0003
246 PRODUCT SUPPLY ISSUE 2 0.0003
247 GOUT 5 0.0003
248 FACIAL BONES FRACTURE 1 0.0003
249 LIVER TRANSPLANT 1 0.0003
250 SPONDYLITIS 1 0.0003
251 RESTLESS LEGS SYNDROME 5 0.0003
252 RECTAL DISCHARGE 1 0.0003
253 FEELING DRUNK 2 0.0003
254 THROAT CLEARING 1 0.0003
255 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
256 PARANASAL SINUS DISCOMFORT 1 0.0003
257 TENDON PAIN 2 0.0003
258 PARANASAL SINUS HYPERSECRETION 1 0.0003
259 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
260 INSURANCE ISSUE 4 0.0003
261 COMMUNICATION DISORDER 1 0.0003
262 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
263 RHINOVIRUS INFECTION 1 0.0003
264 BRAIN FOG 4 0.0003
265 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
266 BLOOD IRON DECREASED 3 0.0003
267 WRIST FRACTURE 3 0.0003
268 SENSORY LOSS 2 0.0002
269 ENURESIS 1 0.0002
270 MUSCLE TIGHTNESS 4 0.0002
271 HICCUPS 2 0.0002
272 TONGUE DISCOMFORT 1 0.0002
273 PURULENT DISCHARGE 1 0.0002
274 SHOULDER OPERATION 1 0.0002
275 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
276 TEARFULNESS 1 0.0002
277 LOCAL SWELLING 4 0.0002
278 MELANOCYTIC NAEVUS 1 0.0002
279 GLOSSODYNIA 5 0.0002
280 ANAL INCONTINENCE 2 0.0002
281 SINUS CONGESTION 3 0.0002
282 URINARY TRACT DISORDER 1 0.0002
283 OROPHARYNGEAL DISCOMFORT 2 0.0002
284 URINE ABNORMALITY 1 0.0002
285 DISEASE COMPLICATION 1 0.0002
286 NEPHROGENIC ANAEMIA 1 0.0002
287 PRODUCT DISTRIBUTION ISSUE 2 0.0002
288 ARTHRITIS INFECTIVE 1 0.0002
289 NECK PAIN 12 0.0002
290 DEVICE OCCLUSION 3 0.0002
291 PAIN IN JAW 6 0.0002
292 SPINAL COLUMN STENOSIS 1 0.0002
293 SPUTUM DISCOLOURED 2 0.0002
294 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
295 PRODUCT PACKAGING ISSUE 2 0.0002
296 VULVOVAGINAL PAIN 1 0.0002
297 HUMERUS FRACTURE 1 0.0002
298 ANOSMIA 3 0.0002
299 RASH VESICULAR 1 0.0002
300 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
301 EAR PAIN 4 0.0002
302 INCORRECT DOSAGE ADMINISTERED 1 0.0002
303 PHARYNGEAL SWELLING 2 0.0002
304 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
305 VITREOUS FLOATERS 2 0.0002
306 NASAL POLYPS 1 0.0002
307 BREATH SOUNDS ABNORMAL 1 0.0002
308 LIGAMENT SPRAIN 2 0.0002
309 PULMONARY MASS 3 0.0002
310 HEPATIC ENZYME ABNORMAL 1 0.0002
311 SALIVARY HYPERSECRETION 2 0.0002
312 FLUID INTAKE REDUCED 1 0.0002
313 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
314 TOOTH ABSCESS 2 0.0002
315 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
316 TENDONITIS 3 0.0002
317 VARICOSE VEIN 1 0.0002
318 POOR VENOUS ACCESS 2 0.0002
319 TENDERNESS 2 0.0002
320 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
321 WEIGHT FLUCTUATION 2 0.0002
322 FOOD CRAVING 1 0.0002
323 BLOOD LACTIC ACID INCREASED 1 0.0002
324 INCONTINENCE 2 0.0002
325 ULCER 3 0.0002
326 SCIATICA 3 0.0002
327 JOINT INJURY 4 0.0002
328 FOOD POISONING 1 0.0002
329 PRODUCT DELIVERY MECHANISM ISSUE 1 0.0002
330 INTESTINAL RESECTION 1 0.0002
331 BRUXISM 1 0.0002
332 JAW DISORDER 1 0.0002
333 FAECALOMA 1 0.0002
334 ON AND OFF PHENOMENON 1 0.0002
335 HEART RATE ABNORMAL 1 0.0002
336 WOUND 5 0.0002
337 ORAL PAIN 4 0.0002
338 SKIN INFECTION 2 0.0002
339 PRODUCT LEAKAGE 1 0.0002
340 PERIORBITAL SWELLING 1 0.0002
341 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
342 CHOLECYSTECTOMY 2 0.0002
343 MYOCARDITIS 2 0.0002
344 MUSCULOSKELETAL DISCOMFORT 3 0.0002
345 CORONARY ARTERY BYPASS 1 0.0002
346 BLOOD URIC ACID INCREASED 1 0.0002
347 SKIN WARM 1 0.0002
348 PRODUCT LABEL CONFUSION 1 0.0002
349 SPINAL PAIN 2 0.0002
350 URINE ODOUR ABNORMAL 1 0.0002
351 CATARACT OPERATION 1 0.0002
352 SINUS HEADACHE 1 0.0002
353 BLOOD POTASSIUM DECREASED 5 0.0002
354 GANGRENE 1 0.0002
355 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
356 ARTHRITIS 13 0.0002
357 FIBROMYALGIA 4 0.0002
358 NEURALGIA 4 0.0002
359 VULVOVAGINAL BURNING SENSATION 1 0.0002
360 MENISCUS INJURY 1 0.0002
361 NASAL DRYNESS 1 0.0002
362 FOOT FRACTURE 3 0.0002
363 PHOTOPSIA 1 0.0002
364 BLOOD URINE PRESENT 3 0.0002
365 HEAD INJURY 5 0.0002
366 FLUID RETENTION 8 0.0002
367 POST PROCEDURAL COMPLICATION 3 0.0002
368 PROCTALGIA 1 0.0002
369 BACK PAIN 36 0.0002
370 HAEMORRHOIDS 3 0.0002
371 TENDON DISORDER 1 0.0002
372 NODULE 2 0.0002
373 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
374 POLYP 1 0.0002
375 IMMUNE SYSTEM DISORDER 2 0.0002
376 SINUS DISORDER 3 0.0002
377 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
378 EYE HAEMORRHAGE 2 0.0001
379 SKIN MASS 1 0.0001
380 SPINAL FRACTURE 3 0.0001
381 TERMINAL STATE 1 0.0001
382 PAIN IN EXTREMITY 44 0.0001
383 FULL BLOOD COUNT DECREASED 3 0.0001
384 BRONCHIECTASIS 1 0.0001
385 METASTASES TO LYMPH NODES 1 0.0001
386 OCULAR HYPERAEMIA 7 0.0001
387 PRODUCT LABEL ISSUE 1 0.0001
388 PRODUCTIVE COUGH 7 0.0001
389 CONTUSION 14 0.0001
390 RESPIRATION ABNORMAL 1 0.0001
391 DROOLING 1 0.0001
392 HAIR GROWTH ABNORMAL 1 0.0001
393 PROCEDURAL PAIN 4 0.0001
394 ORAL DISCOMFORT 2 0.0001
395 FEELING COLD 4 0.0001
396 HAEMOPTYSIS 4 0.0001
397 APHONIA 2 0.0001
398 APPLICATION SITE REACTION 1 0.0001
399 HAND FRACTURE 1 0.0001
400 URINARY TRACT INFECTION 24 0.0001
401 PANIC REACTION 1 0.0001
402 FALL 46 0.0001
403 DEVICE DISLOCATION 6 0.0001
404 FAECES SOFT 1 0.0001
405 RASH PUSTULAR 1 0.0001
406 SINUSITIS 14 0.0001
407 NASAL CONGESTION 8 0.0001
408 CEREBRAL DISORDER 1 0.0001
409 TOOTH DISORDER 3 0.0001
410 COLON CANCER 2 0.0001
411 THERAPY NON-RESPONDER 6 0.0001
412 BREAST TENDERNESS 1 0.0001
413 HYPOAESTHESIA ORAL 2 0.0001
414 APPLICATION SITE PRURITUS 3 0.0001
415 DEVICE FAILURE 2 0.0001
416 HIP ARTHROPLASTY 2 0.0001
417 THYROID DISORDER 2 0.0001
418 CONCUSSION 1 0.0001
419 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
420 THERAPY PARTIAL RESPONDER 2 0.0001
421 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
422 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
423 MUSCULOSKELETAL STIFFNESS 11 0.0001
424 ATRIAL FLUTTER 1 0.0001
425 FRUSTRATION TOLERANCE DECREASED 1 0.0001
426 MUSCLE DISORDER 1 0.0001
427 FLATULENCE 7 0.0001
428 POST PROCEDURAL INFECTION 1 0.0001
429 LUNG DISORDER 6 0.0001
430 ABNORMAL FAECES 1 0.0001
431 METASTASES TO BONE 2 0.0001
432 HYPERAESTHESIA 1 0.0001
433 HAIR DISORDER 1 0.0001
434 MENSTRUAL DISORDER 1 0.0001
435 AGEUSIA 3 0.0001
436 SKIN DISORDER 4 0.0001
437 BONE PAIN 7 0.0001
438 CIRCULATORY COLLAPSE 2 0.0001
439 FACIAL PARALYSIS 1 0.0001
440 PERIPHERAL SWELLING 18 0.0001
441 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
442 SKIN ULCER 3 0.0001
443 PARANOIA 2 0.0001
444 RESPIRATORY TRACT INFECTION 3 0.0001
445 DEVICE USE ISSUE 2 0.0001
446 NAIL DISORDER 1 0.0001
447 COUGH 32 0.0001
448 BLOOD CALCIUM INCREASED 1 0.0001
449 GROIN PAIN 1 0.0001
450 SPINAL OSTEOARTHRITIS 1 0.0001
451 GRIP STRENGTH DECREASED 1 0.0001
452 COLD SWEAT 2 0.0001
453 MYOSITIS 1 0.0001
454 ARTHRALGIA 46 0.0001
455 LIP DRY 1 0.0001
456 PNEUMONIA BACTERIAL 1 0.0001
457 INCREASED TENDENCY TO BRUISE 1 0.0001
458 IRON DEFICIENCY ANAEMIA 1 0.0001
459 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
460 BRONCHITIS 8 0.0001
461 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
462 PERSONALITY CHANGE 1 0.0001
463 THINKING ABNORMAL 2 0.0001
464 MIDDLE INSOMNIA 2 0.0001
465 DIARRHOEA HAEMORRHAGIC 1 0.0001
466 ILLNESS 11 0.0001
467 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
468 FLANK PAIN 1 0.0001
469 ARTERIOSCLEROSIS 1 0.0001
470 DYSPNOEA EXERTIONAL 4 0.0001
471 HALLUCINATION 8 0.0001
472 LEUKAEMIA 1 0.0001
473 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
474 PAIN 65 0.0001
475 SPINAL DISORDER 1 0.0001
476 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
477 LETHARGY 6 0.0001
478 LOWER LIMB FRACTURE 2 0.0001
479 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
480 ATELECTASIS 1 0.0001
481 HERNIA 2 0.0001
482 DIZZINESS POSTURAL 1 0.0001
483 NEEDLE ISSUE 3 0.0001
484 AUTOIMMUNE DISORDER 1 0.0001
485 SKIN FISSURES 2 0.0001
486 RENAL TUBULAR NECROSIS 1 0.0001
487 THERAPY CHANGE 1 0.0001
488 BODY TEMPERATURE DECREASED 1 0.0001
489 HOSPICE CARE 1 0.0001
490 DISABILITY 2 0.0001
491 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
492 CATARACT 6 0.0001
493 BLADDER DISORDER 1 0.0001
494 BLOOD PRESSURE ABNORMAL 2 0.0001
495 UPPER LIMB FRACTURE 2 0.0001
496 DEVICE ISSUE 9 0.0001
497 BURNING SENSATION 7 0.0001
498 CELLULITIS 5 0.0001
499 EMPHYSEMA 1 0.0001
500 PRODUCT ADMINISTRATION ERROR 2 0.0001
501 DRY MOUTH 8 0.0001
502 EYELID PTOSIS 1 0.0001
503 DRY THROAT 1 0.0001
504 DRUG LEVEL DECREASED 1 0.0001
505 MOTOR DYSFUNCTION 1 0.0001
506 SLUGGISHNESS 1 0.0001
507 INITIAL INSOMNIA 1 0.0001
508 EAR DISCOMFORT 1 0.0001
509 TEMPERATURE INTOLERANCE 1 0.0001
510 EYE DISCHARGE 1 0.0001
511 SWELLING 9 0.0001
512 SWOLLEN TONGUE 3 0.0001
513 PETECHIAE 1 0.0001
514 NERVOUSNESS 5 0.0001
515 DERMATITIS 2 0.0001
516 KNEE ARTHROPLASTY 2 0.0001
517 SCRATCH 1 0.0001
518 RENAL PAIN 1 0.0001
519 RETCHING 2 0.0001
520 BREAST PAIN 1 0.0001
521 IMPAIRED WORK ABILITY 2 0.0001
522 HEREDITARY ANGIOEDEMA 1 0.0001
523 SKIN LACERATION 1 0.0001
524 BACK INJURY 1 0.0001
525 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
526 TOOTH FRACTURE 1 0.0001
527 STEVENS-JOHNSON SYNDROME 2 0.0001
528 GAIT INABILITY 3 0.0001
529 ABDOMINAL DISCOMFORT 15 0.0001
530 OCULAR DISCOMFORT 1 0.0001
531 OXYGEN SATURATION DECREASED 5 0.0001
532 HEART RATE IRREGULAR 2 0.0001
533 PRODUCT DOSE OMISSION ISSUE 26 0.0001
534 IMPAIRED DRIVING ABILITY 1 0.0001
535 SCAB 1 0.0001
536 MICTURITION URGENCY 1 0.0001
537 NEPHROLITHIASIS 4 0.0001
538 SKIN DISCOLOURATION 4 0.0001
539 METASTASES TO LUNG 1 0.0001
540 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
541 DYSPHONIA 5 0.0001
542 COVID-19 PNEUMONIA 1 0.0001
543 SOMNOLENCE 17 0.0001
544 WHEEZING 5 0.0001
545 BACTERAEMIA 1 0.0001
546 NEUROPATHY PERIPHERAL 8 0.0001
547 PRODUCT ADHESION ISSUE 3 0.0001
548 ACCIDENT 1 0.0001
549 MULTIPLE SCLEROSIS 4 0.0001
550 JOINT SWELLING 10 0.0001
551 HEPATITIS C 1 0.0001
552 DRUG EFFECT INCOMPLETE 3 0.0001
553 STOMATITIS 5 0.0001
554 MYALGIA 14 0.0001
555 PANIC ATTACK 3 0.0001
556 DISCOMFORT 5 0.0001
557 MUSCLE SPASMS 15 0.0001
558 NASOPHARYNGITIS 15 0.0001
559 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
560 CARDIOMEGALY 1 0.0001
561 SMALL INTESTINAL OBSTRUCTION 1 0.0001
562 PHARYNGITIS 1 0.0001
563 CYST 1 0.0001
564 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
565 CONFUSIONAL STATE 13 0.0001
566 PNEUMONIA ASPIRATION 2 0.0001
567 INTENTIONAL PRODUCT MISUSE 7 0.0001
568 ASTHENIA 30 0.0001
569 FATIGUE 62 0.0001
570 WEIGHT DECREASED 22 0.0001
571 CARDIOVASCULAR DISORDER 2 0.0001
572 GAIT DISTURBANCE 15 0.0001
573 CHEST DISCOMFORT 8 0.0001
574 THERAPY CESSATION 4 0.0001
575 ABDOMINAL PAIN UPPER 16 0.0001
576 INFLAMMATION 4 0.0001
577 UNRESPONSIVE TO STIMULI 2 0.0001
578 RHINORRHOEA 5 0.0001
579 HIATUS HERNIA 1 0.0001
580 PNEUMONIA 25 0.0001
581 SEDATION 2 0.0001
582 MUSCULOSKELETAL PAIN 4 0.0001
583 INCORRECT PRODUCT STORAGE 1 0.0001
584 BEDRIDDEN 1 0.0001
585 GASTRITIS 2 0.0001
586 ORAL CANDIDIASIS 1 0.0001
587 DIARRHOEA 49 0.0001
588 SARS-COV-2 TEST POSITIVE 1 0.0001
589 DEPRESSED MOOD 4 0.0001
590 DYSMENORRHOEA 1 0.0001
591 ADVERSE REACTION 1 0.0001
592 EAR INFECTION 2 0.0001
593 HAIR TEXTURE ABNORMAL 1 0.0001
594 QUALITY OF LIFE DECREASED 1 0.0001
595 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
596 THROAT TIGHTNESS 2 0.0001
597 DEVICE BREAKAGE 3 0.0001
598 OEDEMA PERIPHERAL 9 0.0001
599 PNEUMONITIS 2 0.0001
600 DRUG TOXICITY 1 0.0001
601 IMPAIRED GASTRIC EMPTYING 1 0.0001
602 APPLICATION SITE RASH 1 0.0001
603 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
604 ABNORMAL DREAMS 2 0.0001
605 DIVERTICULITIS 2 0.0001
606 MENTAL STATUS CHANGES 2 0.0001
607 ARTHROPATHY 4 0.0001
608 HEADACHE 45 0.0001
609 CARPAL TUNNEL SYNDROME 1 0.0001
610 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
611 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
612 INTENTIONAL DOSE OMISSION 2 0.0001
613 BRONCHOSPASM 1 0.0001
614 RED BLOOD CELL COUNT DECREASED 2 0.0001
615 SKIN BURNING SENSATION 5 0.0001
616 IMPAIRED QUALITY OF LIFE 1 0.0001
617 PARAESTHESIA ORAL 1 0.0001
618 PANCREATIC CARCINOMA 2 0.0001
619 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
620 SEPTIC SHOCK 3 0.0001
621 APATHY 1 0.0001
622 ASCITES 2 0.0001
623 ACUTE MYOCARDIAL INFARCTION 2 0.0001
624 PRURITUS 26 0.0001
625 LIVER DISORDER 3 0.0001
626 SKIN HAEMORRHAGE 1 0.0001
627 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
628 RESPIRATORY DISORDER 2 0.0001
629 EPISTAXIS 5 0.0001
630 FEELING ABNORMAL 16 0.0001
631 HOT FLUSH 5 0.0001
632 OSTEOPENIA 1 0.0001
633 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
634 URTICARIA 11 0.0001
635 DRUG ADMINISTRATION ERROR 2 0.0001
636 DEVICE RELATED INFECTION 1 0.0001
637 EMOTIONAL DISORDER 2 0.0001
638 LIMB DISCOMFORT 2 0.0001
639 FEMUR FRACTURE 2 0.0001
640 DELUSION 1 0.0001
641 CONSTIPATION 14 0.0001
642 CARDIAC DISORDER 6 0.0001
643 BASAL CELL CARCINOMA 1 0.0001
644 PRODUCT USE COMPLAINT 1 0.0001
645 RESPIRATORY TRACT CONGESTION 1 0.0001
646 HALLUCINATION, AUDITORY 1 0.0001
647 CYSTITIS 2 0.0001
648 INFLUENZA 7 0.0001
649 SENSORY DISTURBANCE 1 0.0001
650 MOVEMENT DISORDER 2 0.0001
651 HIP FRACTURE 2 0.0001
652 NIGHT SWEATS 2 0.0001
653 MUSCULAR WEAKNESS 7 0.0001
654 BLOOD POTASSIUM INCREASED 1 0.0001
655 HYPERTENSION 13 0.0001
656 DYSPEPSIA 6 0.0001
657 EYE DISORDER 2 0.0001
658 INFLUENZA LIKE ILLNESS 5 0.0001
659 STAPHYLOCOCCAL INFECTION 2 0.0001
660 HEART RATE INCREASED 6 0.0001
661 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
662 DRY EYE 3 0.0001
663 LIP SWELLING 2 0.0001
664 RENAL IMPAIRMENT 5 0.0001
665 TYPE 2 DIABETES MELLITUS 2 0.0001
666 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
667 SKIN EXFOLIATION 5 0.0001
668 HEMIPARESIS 1 0.0001
669 GASTRIC DISORDER 2 0.0001
670 NIGHTMARE 2 0.0001
671 DEVICE DEFECTIVE 1 0.0001
672 DELIRIUM 2 0.0001
673 HAEMORRHAGE 6 0.0001
674 RASH MACULAR 2 0.0001
675 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
676 METASTASES TO LIVER 1 0.0001
677 SLEEP DISORDER 4 0.0001
678 LYMPHOCYTE COUNT DECREASED 1 0.0001
679 VISUAL IMPAIRMENT 7 0.0001
680 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
681 INSOMNIA 15 0.0001
682 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
683 ISCHAEMIC STROKE 1 0.0001
684 GASTROENTERITIS VIRAL 1 0.0001
685 RASH PRURITIC 3 0.0001
686 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
687 INFECTION 8 0.0001
688 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
689 END STAGE RENAL DISEASE 1 0.0001
690 DYSPNOEA 31 0.0001
691 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
692 ANAPHYLACTIC REACTION 3 0.0001
693 OROPHARYNGEAL PAIN 5 0.0001
694 DYSGEUSIA 4 0.0001
695 EYE SWELLING 2 0.0001
696 HEPATIC FUNCTION ABNORMAL 2 0.0001
697 HYPOAESTHESIA 8 0.0001
698 HEPATIC CIRRHOSIS 1 0.0001
699 INTESTINAL OBSTRUCTION 2 0.0001
700 BLOOD SODIUM DECREASED 1 0.0001
701 RHEUMATOID ARTHRITIS 6 0.0001
702 FRACTURE 1 0.0001
703 COLITIS 2 0.0001
704 MUSCULOSKELETAL DISORDER 1 0.0001
705 PRODUCT USE IN UNAPPROVED INDICATION 13 0.0001
706 SLEEP APNOEA SYNDROME 1 0.0001
707 MIGRAINE 5 0.0001
708 INCREASED APPETITE 1 0.0001
709 BLOOD PRESSURE INCREASED 8 0.0001
710 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
711 CHOLESTASIS 1 0.0001
712 DRUG PRESCRIBING ERROR 1 0.0001
713 ACUTE RESPIRATORY FAILURE 1 0.0001
714 ERUCTATION 1 0.0001
715 PRESCRIBED OVERDOSE 1 0.0001
716 DECREASED APPETITE 12 0.0001
717 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
718 PALPITATIONS 6 0.0001
719 VISION BLURRED 7 0.0001
720 KIDNEY INFECTION 1 0.0001
721 HAEMATOCRIT DECREASED 1 0.0001
722 PRESCRIBED UNDERDOSE 1 0.0001
723 SYNCOPE 5 0.0000
724 CARDIAC FAILURE 4 0.0000
725 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
726 FEEDING DISORDER 1 0.0000
727 DYSKINESIA 2 0.0000
728 BONE MARROW FAILURE 1 0.0000
729 BODY TEMPERATURE INCREASED 1 0.0000
730 PRODUCT PREPARATION ERROR 1 0.0000
731 CHEST PAIN 9 0.0000
732 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
733 HYPERSENSITIVITY 9 0.0000
734 PERITONITIS 1 0.0000
735 TREMOR 8 0.0000
736 DIZZINESS 24 0.0000
737 PULMONARY HYPERTENSION 1 0.0000
738 ROAD TRAFFIC ACCIDENT 2 0.0000
739 ANAEMIA 9 0.0000
740 OSTEOARTHRITIS 2 0.0000
741 EATING DISORDER 1 0.0000
742 PLATELET COUNT DECREASED 5 0.0000
743 LIVER FUNCTION TEST INCREASED 1 0.0000
744 POOR QUALITY SLEEP 1 0.0000
745 DEEP VEIN THROMBOSIS 3 0.0000
746 FAECES DISCOLOURED 1 0.0000
747 COVID-19 8 0.0000
748 BLOOD PRESSURE DECREASED 3 0.0000
749 DEHYDRATION 6 0.0000
750 THROMBOCYTOPENIA 5 0.0000
751 GASTROINTESTINAL DISORDER 4 0.0000
752 SNEEZING 1 0.0000
753 THROAT IRRITATION 2 0.0000
754 PANCREATITIS ACUTE 1 0.0000
755 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
756 CHROMATURIA 1 0.0000
757 ASTHMA 5 0.0000
758 DEPRESSION 10 0.0000
759 PRODUCT AVAILABILITY ISSUE 1 0.0000
760 RASH 19 0.0000
761 PYREXIA 15 0.0000
762 ABDOMINAL PAIN 10 0.0000
763 RENAL DISORDER 2 0.0000
764 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
765 COGNITIVE DISORDER 2 0.0000
766 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
767 CHILLS 5 0.0000
768 PRODUCT USE ISSUE 8 0.0000
769 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
770 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
771 RASH ERYTHEMATOUS 2 0.0000
772 MOBILITY DECREASED 3 0.0000
773 NAUSEA 33 0.0000
774 HEPATIC CANCER 1 0.0000
775 ENCEPHALOPATHY 1 0.0000
776 WEIGHT INCREASED 9 0.0000
777 HYPOTENSION 8 0.0000
778 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
779 PRODUCT COMPLAINT 1 0.0000
780 DIABETES MELLITUS 3 0.0000
781 FLUSHING 4 0.0000
782 INJECTION SITE SWELLING 3 0.0000
783 HYPOPHAGIA 1 0.0000
784 LOSS OF CONSCIOUSNESS 5 0.0000
785 HAEMOGLOBIN DECREASED 4 0.0000
786 ERECTILE DYSFUNCTION 1 0.0000
787 ERYTHEMA 8 0.0000
788 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
789 HYPERHIDROSIS 5 0.0000
790 ANAPHYLACTIC SHOCK 1 0.0000
791 ANXIETY 11 0.0000
792 HAEMATOMA 1 0.0000
793 DIPLOPIA 1 0.0000
794 ABDOMINAL DISTENSION 4 0.0000
795 DEAFNESS 1 0.0000
796 SPEECH DISORDER 2 0.0000
797 DERMATITIS ATOPIC 2 0.0000
798 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
799 INJECTION SITE BRUISING 3 0.0000
800 BLOOD GLUCOSE INCREASED 7 0.0000
801 PAIN OF SKIN 1 0.0000
802 FREQUENT BOWEL MOVEMENTS 1 0.0000
803 BLOOD BILIRUBIN INCREASED 1 0.0000
804 OEDEMA 2 0.0000
805 PRODUCT QUALITY ISSUE 5 0.0000
806 NEUTROPENIA 5 0.0000
807 MOOD ALTERED 1 0.0000
808 HAEMATOCHEZIA 2 0.0000
809 RESPIRATORY DISTRESS 1 0.0000
810 SEPSIS 4 0.0000
811 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
812 EYE IRRITATION 2 0.0000
813 BALANCE DISORDER 3 0.0000
814 DYSSTASIA 1 0.0000
815 MALAISE 15 0.0000
816 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
817 VOMITING 16 0.0000
818 PSYCHOTIC DISORDER 1 0.0000
819 DISEASE PROGRESSION 4 0.0000
820 URINARY INCONTINENCE 1 0.0000
821 RENAL INJURY 1 0.0000
822 HEPATIC FAILURE 1 0.0000
823 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
824 CONDITION AGGRAVATED 10 0.0000
825 PLEURAL EFFUSION 2 0.0000
826 VERTIGO 2 0.0000
827 DRUG INEFFECTIVE 43 0.0000
828 FEELING HOT 2 0.0000
829 EXPOSURE DURING PREGNANCY 2 0.0000
830 NERVOUS SYSTEM DISORDER 1 0.0000
831 DYSPHAGIA 3 0.0000
832 AMNESIA 2 0.0000
833 SWELLING FACE 2 0.0000
834 VISUAL ACUITY REDUCED 1 0.0000
835 EXPIRED PRODUCT ADMINISTERED 1 0.0000
836 VIRAL INFECTION 1 0.0000
837 FUNGAL INFECTION 1 0.0000
838 URINARY RETENTION 1 0.0000
839 INJECTION SITE PRURITUS 2 0.0000
840 INJECTION SITE PAIN 9 0.0000
841 DEVICE USE ERROR 1 0.0000
842 NEOPLASM PROGRESSION 1 0.0000
843 HYPERKALAEMIA 1 0.0000
844 LYMPHADENOPATHY 1 0.0000
845 THERAPY INTERRUPTED 2 0.0000
846 DEATH 24 0.0000
847 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
848 C-REACTIVE PROTEIN INCREASED 1 0.0000
849 HYPERGLYCAEMIA 1 0.0000
850 OFF LABEL USE 24 0.0000
851 DYSURIA 1 0.0000
852 DYSARTHRIA 1 0.0000
853 ACNE 2 0.0000
854 CHRONIC KIDNEY DISEASE 2 0.0000
855 INCORRECT DOSE ADMINISTERED 6 0.0000
856 ACUTE KIDNEY INJURY 4 0.0000
857 SEIZURE 3 0.0000
858 PARAESTHESIA 4 0.0000
859 INJECTION SITE HAEMORRHAGE 2 0.0000
860 THROMBOSIS 2 0.0000
861 EXTRA DOSE ADMINISTERED 1 0.0000
862 BLINDNESS 1 0.0000
863 OSTEOPOROSIS 1 0.0000
864 DRUG DOSE OMISSION 4 0.0000
865 INJECTION SITE ERYTHEMA 3 0.0000
866 POLLAKIURIA 1 0.0000
867 WITHDRAWAL SYNDROME 1 0.0000
868 CEREBROVASCULAR ACCIDENT 4 0.0000
869 RECTAL HAEMORRHAGE 1 0.0000
870 DEVICE LEAKAGE 1 0.0000
871 MENTAL DISORDER 1 0.0000
872 PSORIASIS 3 0.0000
873 DRY SKIN 3 0.0000
874 COLITIS ULCERATIVE 1 0.0000
875 PULMONARY OEDEMA 1 0.0000
876 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
877 ADVERSE DRUG REACTION 2 0.0000
878 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
879 SUICIDAL IDEATION 2 0.0000
880 MEMORY IMPAIRMENT 3 0.0000
881 SKIN IRRITATION 1 0.0000
882 TINNITUS 1 0.0000
883 BREAST CANCER 2 0.0000
884 BLOOD CHOLESTEROL INCREASED 1 0.0000
885 PULMONARY EMBOLISM 2 0.0000
886 DISEASE RECURRENCE 1 0.0000
887 BLOOD GLUCOSE DECREASED 1 0.0000
888 DRUG INTOLERANCE 2 0.0000
889 INTERSTITIAL LUNG DISEASE 1 0.0000
890 ATRIAL FIBRILLATION 2 0.0000
891 LEUKOPENIA 1 0.0000
892 AGGRESSION 1 0.0000
893 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
894 ECZEMA 1 0.0000
895 DRUG EFFECT DECREASED 1 0.0000
896 TREATMENT NONCOMPLIANCE 1 0.0000
897 PANCYTOPENIA 1 0.0000
898 HYPONATRAEMIA 1 0.0000
899 EYE PAIN 1 0.0000
900 HERPES ZOSTER 1 0.0000
901 PRODUCT SUBSTITUTION ISSUE 1 0.0000
902 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
903 MYOCARDIAL INFARCTION 3 0.0000
904 IRRITABILITY 1 0.0000
905 THERAPEUTIC RESPONSE DECREASED 1 0.0000
906 ILL-DEFINED DISORDER 1 0.0000
907 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
908 INTENTIONAL OVERDOSE 1 0.0000
909 PRODUCT DOSE OMISSION 1 0.0000
910 DEVICE DIFFICULT TO USE 1 0.0000
911 HEPATIC ENZYME INCREASED 1 0.0000
912 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
913 INJECTION SITE REACTION 1 0.0000
914 DEVICE MALFUNCTION 1 0.0000
915 INJURY 1 0.0000
916 RESPIRATORY FAILURE 1 0.0000
917 UNDERDOSE 1 0.0000
918 AGITATION 1 0.0000
919 UNEVALUABLE EVENT 1 0.0000
920 DRUG INTERACTION 2 0.0000
921 CARDIAC ARREST 1 0.0000
922 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
923 PRODUCT STORAGE ERROR 1 0.0000
924 TACHYCARDIA 1 0.0000
925 ADVERSE EVENT 1 0.0000
926 ALOPECIA 2 0.0000
927 OVERDOSE 2 0.0000
928 RENAL FAILURE 1 0.0000
929 HOSPITALISATION 1 0.0000
930 NO ADVERSE EVENT 1 0.0000